![]() The recent acquisition of Kantar Health, a life sciences data analytics research firm, will help move Cerner’s data business into a billion-dollar revenue stream by the middle of the decade. It’s a market that’s expected to grow to $11 billion by 2024. It was already a growing business pre-covid but is now seen as even more important as stakes were raised by the pandemic. From cancer drugs to covid vaccines, this information helps to speed up discoveries and improve testing accuracies. When collated and examined this data is critical in predicting health outcomes for all. It currently manages the systems of almost 3 million healthcare providers globally, with the data of approximately 250 million patients at their fingertips. The company has big plans to grow its data-as-a-service offering. They provide an important service in that they assist in getting important medical information to the areas that need it, but also play a critical role in stemming the increasing costs of providing healthcare to an aging population. They are the main supplier of health information technology services, as well as being producers of medical devices and hardware. Cerner benefits from this by providing solutions to healthcare providers to help them cut costs in their business models. A constant source of new customers churning off the production line.įor years now global healthcare costs have been rising faster than incomes, and it has been no more pronounced than in the US. That’s the great thing about investing in the healthcare sector. They were still the largest age cohort until they were overtaken by the Millenials just last year – the children of Boomers. ![]() And according to the US Census Bureau, the Boomers have been the largest generation the US has ever had, peaking at 78.8 million in the late ’90s. It’s no surprise that as people age they require more medical treatment. An industry that is expected to grow exponentially in coming years thanks to an aging boomer population. For one, it’s part of the booming healthcare industry. Today’s stock report subject, Cerner, has a lot of great things going for it. Every stock will have a bad run now and then, it’s our job to decipher which ones are just in a dip and which are going to continue to struggle. As long as you still believe that long term the stock will continue to be successful. If the company concerned has strong fundamentals and good management in place, a stock price fall, whether it be from external circumstances or internal issues, can still provide a great opportunity. In the last few stock reports we’ve done we’ve focussed a lot on stocks that have seen some sort of recent pullback, putting them into prime buying range.
0 Comments
Leave a Reply. |